Small‐Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models

Obesity is a growing public health concern, with 37.5% of the adult population in need of therapeutics that are more efficacious with a better side effect profile. An innovative target in this regard is neuromedin U, a neuropeptide shown to suppress food intake and attenuate weight gain in animal mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampson, Catherine M., Kasper, James M., Felsing, Daniel E., Raval, Sweta R., Ye, Na, Wang, Pingyuan, Patrikeev, Igor, Rytting, Erik, Zhou, Jia, Allen, John A., Hommel, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106167/
https://www.ncbi.nlm.nih.gov/pubmed/30151213
http://dx.doi.org/10.1002/prp2.425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106167/
https://www.ncbi.nlm.nih.gov/pubmed/30151213
http://dx.doi.org/10.1002/prp2.425

Ejemplares similares